Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 42Uterine Cervical Neoplasms 41Breast Neoplasms 10Vaginal Neoplasms 6Neoplasms 6Endometrial Neoplasms 6Liver Neoplasms 5Uterine Neoplasms 4Sarcoma 4Lung Neoplasms 4Esophageal Neoplasms 4Vulvar Neoplasms 3Retinoblastoma 3Radiation Injuries 3Ovarian Neoplasms 3Hyperthermia 3Carcinoma, Hepatocellular 3Adenocarcinoma 3Rhabdomyosarcoma 2Rectal Neoplasms 2Melanoma 2Head and Neck Neoplasms 2Gynecologic Cancer 2Desmoplastic Small Round Cell Tumor 2Deglutition Disorders 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Carcinoma In Situ 2Uveal Melanoma 1

Interventions

Surgical Procedures, Operative 1Drug Therapy 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Directly Observed Therapy × Brachytherapy × Clear all
NCT06350825 2024-04-05

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms, Directly Observed Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡